Clinical Trials Browser

Phase 2 × Enrolling by invitation × apatinib × Clear all

NCT06773156 2025-01-14

Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer

Phase 2 Enrolling by invitation

Small Cell Lung Carcinoma